Anpario (LON:ANP) Sets New 12-Month High – Still a Buy?

Shares of Anpario plc (LON:ANP) reached a new 52-week high during trading on Monday . The stock traded as high as GBX 488.55 ($6.18) and last traded at GBX 469 ($5.94), with a volume of 134166 shares traded. The stock had previously closed at GBX 463 ($5.86).

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group upped their target price on shares of Anpario from GBX 380 ($4.81) to GBX 500 ($6.33) and gave the stock a “buy” rating in a research report on Tuesday, January 14th.

Anpario Stock Up 1.3 %

The business has a 50-day moving average of GBX 417.98 and a 200 day moving average of GBX 349.58. The company has a market capitalization of £80.01 million, a PE ratio of 25.90 and a beta of 0.58. The company has a debt-to-equity ratio of 0.10, a current ratio of 6.15 and a quick ratio of 5.16.

Insider Transactions at Anpario

In other news, insider Karen Prior sold 14,000 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.81), for a total transaction of £53,200 ($67,324.73). Insiders own 30.51% of the company’s stock.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.